Livzon Pharmaceutical Group reports stock repurchases on April 14, 2025
Livzon Pharmaceutical Group (SZSE:000513) announced daily reports detailing repurchases of both its H-shares and A-shares on April 14, 2025. There were no changes in the company's issued shares or treasury shares. The number of issued shares, excluding treasury shares, remains at 307,052,417 H-shares and 604,293,313 A-shares. The H-shares repurchases made on April 14, 2025 amount to 144,800 shares for a total of RMB4,998,311 and an average cost of RMB34.52 per share. The number of H-shares and A-shares repurchased in previous transactions but have not been cancelled at this time is also indicated in the announcement.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Livzon Pharmaceutical Group publishes news
Free account required • Unsubscribe anytime